{"id":"https://openalex.org/W7225137906","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0981","title":"981 Tumor-mediated innate training of neutrophil progenitors involves FOXO1 activation and promotes immunotherapy-associated colitis","display_name":"981 Tumor-mediated innate training of neutrophil progenitors involves FOXO1 activation and promotes immunotherapy-associated colitis","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7225137906","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0981"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0981","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0981","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0981","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1119.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/14/Suppl_2/A1119.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014904559","display_name":"Balamayooran Theivanthiran","orcid":"https://orcid.org/0000-0003-4816-199X","observed_orcids":["https://orcid.org/0000-0003-4816-199X"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Balamayooran Theivanthiran","raw_affiliation_strings":["University of North Carolina at Chapel Hill, Pfafftown, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina at Chapel Hill, Pfafftown, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006555210","display_name":"Y\u2010Van Nguyen","orcid":"https://orcid.org/0000-0003-1888-2147","observed_orcids":["https://orcid.org/0000-0003-1888-2147"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y-Van Nguyen","raw_affiliation_strings":["Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051053583","display_name":"Kyra Majors","orcid":"https://orcid.org/0000-0002-4489-7636","observed_orcids":["https://orcid.org/0000-0002-4489-7636"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kyra Majors","raw_affiliation_strings":["Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087094854","display_name":"Michael P. Plebanek","orcid":"https://orcid.org/0000-0002-4966-5199","observed_orcids":["https://orcid.org/0000-0002-4966-5199"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Plebanek","raw_affiliation_strings":["University of North Carolina, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina, Durham, NC, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000755157","display_name":"Brent Allen Hanks","orcid":"https://orcid.org/0000-0002-2803-3272","observed_orcids":["https://orcid.org/0000-0002-2803-3272"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]},{"id":"https://openalex.org/I4390039329","display_name":"UNC Lineberger Comprehensive Cancer Center","ror":"https://ror.org/043ehm030","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brent A Hanks","raw_affiliation_strings":["Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177","https://openalex.org/I4390039329"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1119","last_page":"A1119"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14072","display_name":"Immunotoxicology and immune responses","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7310000061988831},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.8730000257492065},{"id":"https://openalex.org/keywords/immune-mediated-colitis","display_name":"immune-related colitis","score":0.6579999923706055},{"id":"https://openalex.org/keywords/foxo1","display_name":"FOXO1","score":0.8040000200271606},{"id":"https://openalex.org/keywords/nlrp3-inflammasome","display_name":"NLRP3 inflammasome","score":0.9639999866485596},{"id":"https://openalex.org/keywords/hsp70","display_name":"HSP70","score":0.9950000047683716},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.5429999828338623},{"id":"https://openalex.org/keywords/chromatin-accessibility","display_name":"chromatin accessibility","score":0.6589999794960022},{"id":"https://openalex.org/keywords/th17-cells","display_name":"Th17 cells","score":0.7429999709129333},{"id":"https://openalex.org/keywords/il-17a","display_name":"IL-17A","score":0.8180000185966492},{"id":"https://openalex.org/keywords/neutrophil-migration","display_name":"neutrophil migration","score":0.5350000262260437},{"id":"https://openalex.org/keywords/cxcr2","display_name":"CXCR2","score":0.5820000171661377},{"id":"https://openalex.org/keywords/steroid-resistance","display_name":"steroid resistance","score":0.6819999814033508},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.43799999356269836}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7734000086784363},{"id":"https://openalex.org/C140149449","wikidata":"https://www.wikidata.org/wiki/Q17928793","display_name":"FOXO1","level":4,"score":0.6317999958992004},{"id":"https://openalex.org/C2775862500","wikidata":"https://www.wikidata.org/wiki/Q2453464","display_name":"Colitis","level":2,"score":0.5920000076293945},{"id":"https://openalex.org/C201750760","wikidata":"https://www.wikidata.org/wiki/Q1896218","display_name":"Progenitor cell","level":3,"score":0.5087000131607056},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4918000102043152},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.446399986743927},{"id":"https://openalex.org/C134897094","wikidata":"https://www.wikidata.org/wiki/Q7003141","display_name":"Neutrophil extracellular traps","level":3,"score":0.3905999958515167},{"id":"https://openalex.org/C15729860","wikidata":"https://www.wikidata.org/wiki/Q2329919","display_name":"Progenitor","level":4,"score":0.37700000405311584},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.3646000027656555},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.3091000020503998},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2808000147342682},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.27309998869895935}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2026-sitc2026.0981","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0981","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0981","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1119.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2026-sitc2026.0981","doi":"https://doi.org/10.1136/jitc-2026-sitc2026.0981","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2026-sitc2026.0981","pdf_url":"https://jitc.bmj.com/content/14/Suppl_2/A1119.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225137906.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2137428802","https://openalex.org/W4402509774","https://openalex.org/W4389780914","https://openalex.org/W2331718992","https://openalex.org/W4313385057","https://openalex.org/W7125374781","https://openalex.org/W2511835198","https://openalex.org/W4400654854","https://openalex.org/W7222671581","https://openalex.org/W2884777410"],"abstract_inverted_index":{"Background":[0],"Immune":[1],"checkpoint":[2,93,147],"inhibitors":[3],"(ICIs)":[4],"have":[5,45,76,125,192,204],"revolutionized":[6],"the":[7,18,27,90,115,261,303,316,336,368],"treatment":[8,30],"of":[9,20,50,92,260,271,288,318,364,370,378,385],"many":[10,37],"cancers,":[11],"but":[12],"their":[13],"use":[14],"is":[15],"limited":[16],"by":[17,63],"development":[19,91,317,369],"immune-related":[21],"adverse":[22],"events":[23],"(irAEs).":[24],"Corticosteroids":[25],"are":[26],"standard":[28],"first-line":[29],"for":[31],"moderate":[32],"to":[33,41,57,136,171,181,240,266,352],"severe":[34,320],"irAEs;":[35],"however,":[36],"irAEs":[38,321,372],"exhibit":[39,212,252],"resistance":[40],"these":[42,51,274],"agents.":[43],"Neutrophils":[44],"emerged":[46],"as":[47],"key":[48],"mediators":[49],"steroid-refractory":[52],"toxicities.":[53],"Activated":[54],"neutrophils":[55],"contribute":[56],"tissue":[58,300],"damage":[59],"and":[60,70,133,142,161,187,242,257,280,298,305,311,340,373,381],"ongoing":[61],"inflammation":[62],"producing":[64],"reactive":[65],"oxygen":[66],"species,":[67],"releasing":[68],"proteases,":[69],"forming":[71],"neutrophil":[72,86,112,175,275,278,296,365],"extracellular":[73],"traps.":[74],"We":[75,105,124],"demonstrated":[77],"that":[78,107,173,194,203],"a":[79,199,232,375],"tumor-intrinsic":[80,98,108,350],"NLRP3-HSP70":[81],"signaling":[82],"axis":[83,334],"enhances":[84],"systemic":[85],"levels":[87,313],"associated":[88],"with":[89,315],"inhibitor-associated":[94],"colitis.":[95],"However,":[96],"how":[97],"NLRP3":[99,109,351],"influences":[100,367],"toxicity":[101,355],"still":[102],"remained":[103],"unclear.":[104],"hypothesized":[106],"activity":[110,259],"reprograms":[111],"dynamics":[113],"at":[114],"progenitor":[116,247],"level,":[117],"thereby":[118],"facilitating":[119],"inflammatory":[120,214],"colitis":[121,151,178,196,215,237,343],"during":[122,293,344],"immunotherapy.Methods":[123],"applied":[126],"single-cell":[127],"RNAseq/ATAC":[128],"sequencing,":[129],"multi-parameter":[130],"flow":[131,156],"cytometry,":[132,157],"immunofluorescence":[134],"microscopy":[135],"newly":[137],"engineered":[138],"transgenic":[139,186,233],"tumor":[140,189,331,359],"models":[141,145],"tissue-specific":[143],"knockout":[144],"undergoing":[146,327],"inhibitor":[148],"immunotherapy.":[149,345],"Inflammatory":[150],"was":[152],"monitored":[153],"using":[154],"immunohistochemistry,":[155],"micro-PET":[158],"CT":[159],"imaging,":[160],"stool":[162],"calprotectin":[163],"quantification.":[164],"Bone":[165],"marrow":[166,207,220],"chimera":[167],"experiments":[168],"were":[169],"performed":[170],"confirm":[172],"tumor-conditioned":[174],"progenitors":[176,276,366],"mediate":[177],"in":[179,198,231,238,254,273,290,302,322],"response":[180,239],"ICI":[182,244,328],"therapy.Results":[183],"Using":[184],"various":[185],"orthotopic":[188],"models,":[190],"we":[191],"found":[193],"ICI-induced":[195],"develops":[197],"tumor-dependent":[200],"manner.":[201],"Mice":[202],"received":[205],"bone":[206,219],"transplants":[208,221],"from":[209,222,249],"tumor-exposed":[210],"donors":[211,224],"ICI-associated":[213,236],"while":[216,356],"mice":[217,251,268,292],"receiving":[218],"non-tumor-exposed":[223],"do":[225],"not.":[226],"Melanoma-specific":[227],"Nlrp3":[228],"genetic":[229],"silencing":[230],"model":[234],"suppresses":[235],"neoadjuvant":[241],"adjuvant":[243],"therapy.":[245],"Neutrophil":[246],"populations":[248],"tumor-bearing":[250],"alterations":[253],"chromatin":[255],"accessibility":[256],"enhanced":[258],"FOXO1":[262,272,289],"transcription":[263],"factor":[264],"relative":[265],"non-tumor-bearing":[267],"controls.":[269],"Inhibition":[270],"reduces":[277],"proliferation":[279],"differentiation":[281],"into":[282],"CXCR2+":[283],"migratory":[284],"neutrophils.":[285],"Pharmacologic":[286],"inhibition":[287],"melanoma-bearing":[291],"immunotherapy":[294],"inhibited":[295],"accumulation":[297],"TH17":[299],"infiltration":[301],"colon":[304],"attenuated":[306],"toxicity.":[307],"Baseline":[308],"plasma":[309],"HSP70":[310],"IL-17a":[312],"correlate":[314],"more":[319],"stage":[323],"IV":[324],"melanoma":[325],"patients":[326],"therapy.Conclusions":[329],"The":[330],"intrinsic":[332],"NLRP3-FOXO1":[333],"primes":[335],"innate":[337,362],"immune":[338],"compartment":[339],"facilitates":[341],"IL-17-mediated":[342],"These":[346],"findings":[347],"support":[348],"targeting":[349],"mitigate":[353],"immunotherapy-associated":[354],"preserving":[357],"anti-":[358],"efficacy.":[360],"Tumor-mediated":[361],"training":[363],"select":[371],"represents":[374],"novel":[376],"source":[377],"pharmacologic":[379],"targets":[380],"predictive":[382],"biomarkers":[383],"worthy":[384],"future":[386],"clinical":[387],"study.":[388]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-04T00:00:00"}